During the past decade, Nemocnice Slany conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 11 clinical trials were completed, i.e. on average, 39.3% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 9 clinical trials were completed. i.e. 45% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nemocnice Slany" #1 sponsor was "Pfizer" with 8 trials, followed by "Abivax S.A." with 3 trials sponsored, "Bayer" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nemocnice Slany" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 3 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Centre Hospitalier Universitaire de Besancon" with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator and "Ferrer Internacional S.A." with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Nemocnice Slany" are "Ulcerative Colitis" (13 trials), "Atrial Fibrillation" (3 trials), "COVID-19" (3 trials), "Acute Myocardial Infarction" (1 trials) and "Angina Pectoris" (1 trials). Many other conditions were trialed in "Nemocnice Slany" in a lesser frequency.

Most popular intervention types in "Nemocnice Slany" are "Drug" (29 trials), "Other" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Etrasimod" (5 trials), "PF-07321332" (3 trials), "Ritonavir" (3 trials) and "ABX464" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nemocnice Slany" are 31 trials for "All" genders.

Currently, there are NaN active trials in "Nemocnice Slany". undefined are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Nemocnice Slany, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Nemocnice Slany, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Nemocnice Slany has several departments that took part in Clinical trials: "Hospital Slany, Internal Department" - 3 trials